Xtx Topco LTD Pliant Therapeutics, Inc. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$14.58 - $20.15 $1,428 - $1,974	-98 Reduced 0.81%	11,963 $207,000
Q2 2023 Aug 14, 2023	BUY	$18.12 - $30.56 $218,545 - $368,584	12,061 New	12,061 $218,000
Q4 2022 Feb 14, 2023	BUY	$17.0 - $25.43 $236,606 - $353,934	13,918 New	13,918 $269,000
Q2 2022 Aug 15, 2022	BUY	$4.11 - $8.75 $11,738 - $24,990	2,856 Added 22.44%	15,581 $125,000
Q1 2022 May 13, 2022	BUY	$7.01 - $14.1 $89,202 - $179,422	12,725 New	12,725 $89,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.